Product Format
News
Engineered Heart Muscle Allografts for Cardiac Repair in Primates and Humans
2025-02-19
Engineered heart muscle allografts for heart repair in primates and humans
GUK1 activation represents a metabolic vulnerability in lung cancer
2025-02-10
GUK1 activation is a metabolic liability in lung cancer
CD74 abundance serves as a biomarker for identifying the interferon-high immunophenotype
2025-01-27
CD74 abundance serves as a biomarker for identifying the interferon-high immunophenotype
New Findings:A new epigenetic modifications of ESC differentiation
2025-01-20
Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation
New chondrocyte developmental modules and peripheral factors
2025-01-12
The discovery of new chondrocyte developmental modules and peripheral factors that shape height biology and skeletal growth.
A compact epigenetic silencer-CHARM
2025-01-06
CHARM effectively silences the prion protein (PrP) encoding gene throughout the entire brain of mice without altering the DNA sequence.
Advancements in Mesenchymal Stem Cell (MSC) Research Across Various Fields
2024-12-29
On December 18, 2024, the U.S. Food and Drug Administration (FDA) granted official approval for Ryoncil (remestemcel), developed by Mesoblast, making it the first mesenchymal stem cell (MSC) therapy to receive FDA approval. This marks a major milestone in the global stem cell therapy landscape.
共 17 条